Showing results (71-80 of 19,456) with videos related to

Sort By:
Pageof 1,946
Lancet (London, England)|June 5, 1976
Treatment of rosacea by metronidazoleR J Pye, J L Burton
Lancet (London, England)|September 27, 2025
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
Lancet (London, England)|May 17, 2024
StrokeNina A Hilkens, Barbara Casolla, Thomas W Leung, et al.
Lancet (London, England)|July 28, 2024
Differentiating mortality risk of individual infants and children to improve survival: opportunity for impactJames A Berkley, Judd L Walson, Rajiv Bahl, et al.
Lancet (London, England)|October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysisNiklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Lancet (London, England)|October 19, 2025
Community-acquired pneumoniaLuis Felipe Reyes, Andrew Conway Morris, Cristian Serrano-Mayorga, et al.
Lancet (London, England)|May 5, 2022
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Lancet (London, England)|May 21, 2019
Mass gatherings medicine: public health issues arising from mass gathering religious and sporting eventsZiad A Memish, Robert Steffen, Paul White, et al.
Lancet (London, England)|October 10, 2021
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Mahn-Won Park, Min Chul Kim, et al.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Pageof 1,946